Our Mission
The life science industry is about to revolutionize our world in areas such as medicine, pharma, agriculture, and the food industry. For the rapid development of ground-breaking new strategies and products, this industry relies on modern technologies and requires a high degree of automation and digitization.
QUBICON AG combines profound expertise from two disciplines – bioprocessing and software development. We offer a next-level software solution to address challenges across the biotechnological industry and related research fields. Our mission is to innovate bioprocessing by providing the best possible software service to our customers.
Our Story
QUBICON AG originated from a business initiative of Bilfinger Life Science GmbH, which began in Vienna in 2015 in order to tackle the challenges of quality-by-design application in biotechnological processes.
Soon it became clear that a modern, intuitive software with a centralized data platform and advanced control capabilities was required. Since there was no solution meeting this need, we decided to create our own innovative software platform together with software experts from InterFace AG in 2018. Since 2021 QUBICON AG is an independent company, and our software is used by industry clients and leading European life-science universities.
Executive Board
The Executive Board Members of QUBICON AG, Dr. Wolfgang Sommeregger (right) and Olivier Guillet (left), represent over 40 years of industrial and research experience in the fields of biotechnology and software development.
With hands-on experience and future-driven interests, they aim to speed up the transformation towards an industry 4.0. They are always on the lookout for new trends and opportunities to collaborate. Reach out if you have any strategic- or partnership-related questions.
wolfgang.sommeregger@qubicon.io
olivier.guillet@qubicon.io
Katrin has a strong background in product management and software conception and works closely with the development team. Reach out to Katrin regarding any questions on software functions and architecture as well as specific software requirements.
Nataša has several years of experience in up- and downstream bioprocessing. She coordinates the software testing and manages customer requests. Contact Nataša for any software assistance or inquiries for specific use case support.
With his focus on project management and technical sales, Markus is your direct contact if you have any inquiries on realization and implementation of our software at the customer’s site. Feel free to directly reach out to him for further information or any related questions.
With his experience in bioprocess optimization, Marcus is your direct contact for process innovation. He focuses on the project management of our customers and R&D partners and implements proven concepts in our software development process. Directly reach out to him for any bioprocess related software request.
Felix is our most recent addition to the team. He graduated in pharmaceutical biotechnology and focuses on projects with our R&D partners, where he ensures seamless project management and execution. Do not hesitate to reach out to him for any related questions.
Sonja Eschli has a passion for change management and growth as well as years of experience in leading a successful international team in the medical field. Her focus on strategic planning is accompanied by an eye for the bigger picture and a heart for the people she works with. She brings entrepreneurial expertise and specialized knowledge in HR development to the table.
Gerald Berghammer is Product Manager at Bilfinger Life Science GmbH. He has a proven track record in key leadership of Business and R&D units. He focuses on biopharmaceutical innovation, trends, and strategy and has over 25 years of experience in the realization of industrial biopharma production plants.
Tobias is managing director at Daldrop Process GmbH and has more than 20 years of experience in managing companies for equipment, plant installation and engineering for the biotech/pharma industry. He used to be CEO of a global international group and combines this knowledge with the particularities of start-up companies. He recently founded Daldrop Process GmbH servicing the biotech/pharma industry.
Novasign is a bioprocess modeling company focusing on reducing experimental effort during process optimization and characterization. NovaSign developed a hybrid modeling toolbox that reduces experimental effort for optimization tasks by up to 70%.
www.novasign.at
www.boku.ac.at
www.tuwien.at
www.jku.at
www.en.w-hs.de